YD Bio Limited Ordinary Shares (YDES) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    YD Bio Limited Ordinary S...

    NASDAQ: YDES · Real-Time Price · USD
    17.11
    -3.95 (-18.76%)
    At close: Sep 24, 2025, 3:59 PM
    17.46
    2.05%
    After-hours: Sep 24, 2025, 07:35 PM EDT

    YD Bio Ordinary Shares Income Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023
    Period Ending Dec 31, 2024 Dec 31, 2023
    Revenue
    		 510.36K 350.13K
    Cost of Revenue
    		 355K 196.69K
    Gross Profit
    		 155.36K 153.44K
    Operating Income
    		 -1.46M -9.85K
    Interest Income
    		 11.81K 290.00
    Pretax Income
    		 -1.39M 17.65K
    Net Income
    		 -1.41M 13.56K
    Selling & General & Admin
    		 1.13M 160.56K
    Research & Development
    		 491.35K n/a
    Other Expenses
    		 -493 2.73K
    Operating Expenses
    		 1.62M 163.29K
    Interest Expense
    		 772.00 2.14K
    Selling & Marketing Expenses
    		 1.96K 7.49K
    Cost & Expenses
    		 1.97M 359.98K
    Income Tax Expense
    		 25.08K 4.09K
    Shares Outstanding (Basic)
    		 n/a 70.1M
    Shares Outstanding (Diluted)
    		 n/a 70.1M
    EPS (Basic)
    		 n/a 0.00
    EPS (Diluted)
    		 n/a 0.00
    EBITDA
    		 -1.28M 22.25K
    EBIT
    		 -1.39M 19.79K
    Depreciation & Amortization
    		 104.73K 2.45K

    Add to Watchlist